AI-generated summary
This review examines strategies for treating fungal infections, with a focus on paracoccidioidomycosis, including drug combinations, vaccine-like antigens, cellular immunotherapy, and immune-modulating options. The authors propose that low intensity laser therapy and other agents might enhance existing antifungal treatments, but the abstract presents these as proposals rather than tested findings.
- Who or what was studied
- Individuals with fungal infections, particularly paracoccidioidomycosis; the abstract does not describe a specific patient group.
- Limits stated in the abstract
- The abstract does not report any included studies, patient numbers, or outcome data, so the proposed therapies are not shown to be effective.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.